glp-1 receptor agonists and cancer risk in adults with obesity VisualAbstract: Daily Oral Agonist Orforglipron for Glucagon-like peptide-1 receptor agonists and

Hone your obesity medicine skills in primary care

Salminen P, Kow L, Aminian A, et al

J Epidemiol Glob Health , pp

20 Although liraglutide was not shown to improve all aspects of Alzheimer disease, the use of this agent to improve the CMRglc and slow the progression of the disease could lead to better patient outcomes and quality of life

According to the World Health Organization (WHO), alcohol use disorder is associated with 5.3% of deaths and 5.1% of the global burden of disease and injury

Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner